Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Pacific Biosciences of California Inc (NASDAQ: PACB) closed at $1.17 down -2.50% from its previous closing price of $1.20. In other words, the price has decreased by -$2.50 from its previous closing price. On the day, 4.04 million shares were traded. PACB stock price reached its highest trading level at $1.22 during the session, while it also had its lowest trading level at $1.16.
Ratios:
For a deeper understanding of Pacific Biosciences of California Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.59 and its Current Ratio is at 7.48. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.31.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 03 ’25 when HENRY CHRISTIAN O sold 12,497 shares for $1.41 per share. The transaction valued at 17,583 led to the insider holds 2,225,357 shares of the business.
Van Oene Mark sold 6,486 shares of PACB for $9,126 on Mar 03 ’25. The insider now owns 1,497,695 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Farmer Michele, who serves as the insider of the company, sold 2,973 shares for $1.41 each. As a result, the insider received 4,183 and left with 184,619 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 348486816 and an Enterprise Value of 630990080. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.26 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at 4.097 whereas that against EBITDA is -2.529.
Stock Price History:
The Beta on a monthly basis for PACB is 2.10, which has changed by -0.25 over the last 52 weeks, in comparison to a change of 0.05430484 over the same period for the S&P500. Over the past 52 weeks, PACB has reached a high of $2.72, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is -14.38%, while the 200-Day Moving Average is calculated to be -30.63%.
Shares Statistics:
For the past three months, PACB has traded an average of 11.00M shares per day and 9680450 over the past ten days. A total of 294.42M shares are outstanding, with a floating share count of 262.18M. Insiders hold about 11.98% of the company’s shares, while institutions hold 72.68% stake in the company. Shares short for PACB as of 1743379200 were 54601975 with a Short Ratio of 4.96, compared to 1740700800 on 61979163. Therefore, it implies a Short% of Shares Outstanding of 54601975 and a Short% of Float of 20.849999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
